FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18631911000001103: Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Apr 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63888101000001117 Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
63888201000001112 Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Saxagliptin 5mg tablets true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Saxagliptin 5mg tablets false Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Saxagliptin false Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Saxagliptin hydrochloride false Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Onglyza true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Saxagliptin hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has AMP True Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start